Clinical trials recruiting for Cervical Squamous Cell Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALE.P02 | 1 |
| ALE.P03 | 1 |
| Cetuximab | 1 |
| Docetaxel | 1 |
| EVOLVE104 | 1 |
| HMBD-001 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Connecticut | 3 |
| Virginia | 3 |
| Arizona | 2 |
| Illinois | 2 |
| Kentucky | 2 |
| New Jersey | 2 |
| Texas | 2 |
| Georgia | 1 |
| Michigan | 1 |
| New York | 1 |
| North Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
- A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Related conditions
Trials recruiting for Cervical Squamous Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cervical Squamous Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.